Zogenix, Inc. – NASDAQ:ZGNX
Founder-led company
Zogenix stock price today
$26.68
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 2 days
Zogenix stock price monthly change
+2.14%
month
Zogenix stock price quarterly change
+90.84%
quarter
Zogenix stock price yearly change
+32.87%
year
Zogenix key metrics
Market Cap | N/A |
Enterprise value | 1.56B |
P/E | -6.55 |
EV/Sales | 19.11 |
EV/EBITDA | -7.70 |
Price/Sales | 18.29 |
Price/Book | 8.34 |
PEG ratio | 0.76 |
EPS | -4.07 |
Revenue | 81.69M |
EBITDA | -202.57M |
Income | -227.41M |
Revenue Q/Q | 212.96% |
Revenue Y/Y | 498.77% |
Profit margin | -278.38% |
Oper. margin | -274.32% |
Gross margin | 94.08% |
EBIT margin | -274.32% |
EBITDA margin | -247.98% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeZogenix stock price history
Zogenix stock forecast
Zogenix financial statements
| Mar 2021 | 13.68M | -55.63M | -406.53% |
|---|---|---|---|
| Jun 2021 | 18.78M | -58.89M | -313.46% |
| Sep 2021 | 22.61M | -58.00M | -256.54% |
| Dec 2021 | 26.60M | -54.88M | -206.27% |
| 2021-05-06 | -1.02 | -1 |
|---|---|---|
| 2021-08-05 | -0.93 | -1.05 |
| 2021-11-04 | -0.96 | -1.04 |
| 2022-02-28 | -0.88 | -0.98 |
| Mar 2021 | 580964000 | 259.68M | 44.7% |
|---|---|---|---|
| Jun 2021 | 540073000 | 267.21M | 49.48% |
| Sep 2021 | 496987000 | 272.68M | 54.87% |
| Dec 2021 | 468489000 | 289.51M | 61.8% |
| Mar 2021 | -53.85M | -10.85M | -15.89M |
|---|---|---|---|
| Jun 2021 | -42.93M | 94.66M | 1.03M |
| Sep 2021 | -47.38M | 17.27M | -2.83M |
| Dec 2021 | -41.13M | 36.30M | -134K |
Zogenix alternative data
| Aug 2023 | 327 |
|---|---|
| Sep 2023 | 327 |
| Oct 2023 | 327 |
| Nov 2023 | 327 |
| Dec 2023 | 327 |
| Jan 2024 | 327 |
| Feb 2024 | 327 |
| Mar 2024 | 327 |
| Apr 2024 | 327 |
| May 2024 | 327 |
| Jun 2024 | 327 |
| Jul 2024 | 327 |
Zogenix other data
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| May 2021 | 15000 | 0 |
| Jun 2021 | 5584 | 0 |
| Aug 2021 | 10000 | 0 |
| Nov 2021 | 0 | 5305 |
| Jan 2022 | 0 | 15000 |
| Feb 2022 | 0 | 1250 |
| Quarter | Transcript |
|---|---|
| Q3 2021 4 Nov 2021 | Q3 2021 Earnings Call Transcript |
| Q2 2021 6 Aug 2021 | Q2 2021 Earnings Call Transcript |
| Q1 2021 6 May 2021 | Q1 2021 Earnings Call Transcript |
| Q4 2020 25 Feb 2021 | Q4 2020 Earnings Call Transcript |
-
What's the price of Zogenix stock today?
One share of Zogenix stock can currently be purchased for approximately $26.68.
-
When is Zogenix's next earnings date?
Unfortunately, Zogenix's (ZGNX) next earnings date is currently unknown.
-
Does Zogenix pay dividends?
No, Zogenix does not pay dividends.
-
What is Zogenix's stock symbol?
Zogenix, Inc. is traded on the NASDAQ under the ticker symbol "ZGNX".
-
What is Zogenix's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Zogenix?
Shares of Zogenix can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Zogenix's key executives?
Zogenix's management team includes the following people:
- Dr. Stephen J. Farr Co-Founder, Chief Executive Officer, Pres & Director(age: 66, pay: $1,020,000)
- Ms. Shawnte M. Mitchell Executive Vice President, Gen. Counsel & Sec.(age: 47, pay: $715,400)
- Dr. Bradley S. Galer Executive Vice President & Chief Medical Officer(age: 63, pay: $641,620)
- Dr. Gail M. Farfel Executive Vice President & Chief Devel. Officer(age: 61, pay: $638,120)
- Mr. Michael P. Smith Executive Vice President, Chief Financial Officer & Treasurer(age: 57, pay: $633,590)
- Mr. Ashish M. Sagrolikar Executive Vice President & Chief Operating Officer(age: 58, pay: $616,980)
-
Is Zogenix founder-led company?
Yes, Zogenix is a company led by its founder Dr. Stephen J. Farr.
-
How many employees does Zogenix have?
As Jul 2024, Zogenix employs 327 workers.
-
When Zogenix went public?
Zogenix, Inc. is publicly traded company for more then 14 years since IPO on 23 Nov 2010.
-
What is Zogenix's official website?
The official website for Zogenix is zogenix.com.
-
Where are Zogenix's headquarters?
Zogenix is headquartered at 5959 Horton St Ste 500, Emeryville, CALIFORNIA.
-
How can i contact Zogenix?
Zogenix's mailing address is 5959 Horton St Ste 500, Emeryville, CALIFORNIA and company can be reached via phone at +1 510 550 8300.
Zogenix company profile:
Zogenix, Inc.
zogenix.comExchange:
NASDAQ
Full time employees:
327
Industry:
Biotechnology
Sector:
Healthcare
Zogenix, Inc., a biopharmaceutical company, develops and commercializes therapies to transform the lives of patients and their families living with rare diseases in the United States. The company's lead product candidate is the Fintepla, a low-dose fenfluramine, which is in Phase III clinical trials for the treatment of seizures associated with Dravet syndrome, as well as to treat seizures associated with Lennox-Gastaut syndrome; and that is in Phase II clinical trials for the treatment of other rare epileptic syndromes and diseases. It is also developing MT1621, an investigational therapy for the treatment of a rare genetic disorder called thymidine kinase 2 deficiency. Zogenix, Inc. has a collaboration with Tevard Biosciences for the research, development and commercialization of novel gene therapies for Dravet Syndrome and other genetic epilepsies. The company was formerly known as SJ2 Therapeutics, Inc. and changed its name to Zogenix, Inc. in August 2006. Zogenix, Inc. was incorporated in 2006 and is headquartered in Emeryville, California.
5959 Horton St Ste 500
Emeryville, CALIFORNIA 94608
Emeryville, CALIFORNIA 94608
CIK: 0001375151
ISIN: US98978L2043
CUSIP: 98978L204
